Impacts of Mitochondrial-targeted Antioxidant on Peripheral Artery Disease Patients

Clinical trial NCT03506633 · COMPLETED

Trial details

NCT number: NCT03506633
Sponsor: University of Nebraska
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Peripheral Arterial Disease Peripheral Artery Disease

Start date: 2018-09-05
Primary completion: 2022-01-17
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.